arcadia

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2535.60-29.9 (-1.17 %)
PREV CLOSE ( ) 2565.50
OPEN PRICE ( ) 2588.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2535.60 (41)
VOLUME 95515
TODAY'S LOW / HIGH ( )2507.00 2607.50
52 WK LOW / HIGH ( )1888 2875
NSE2536.90-28.65 (-1.12 %)
PREV CLOSE( ) 2565.55
OPEN PRICE ( ) 2583.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2536.90 (304)
VOLUME 2269798
TODAY'S LOW / HIGH( ) 2505.10 2610.00
52 WK LOW / HIGH ( )1872.95 2878
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
18Feb Dr. Reddy's Lab gets EIR for formulati
Dr. Reddy's Laboratories has received Establishment Inspection Report (E..
12Feb Dr. Reddy's launches Tadalafil tablets
Dr. Reddy's Laboratories has launched Tadalafil Tablets USP, a therapeut..
07Feb United Healthcare Services files compl
United Healthcare Services has filed a complaint against Dr Reddy's Labo..
06Feb Dr. Reddy's Laboratories’ arm continu
Dr. Reddy's Laboratories’ wholly-owned subsidiary in USA is continuing i..
04Feb Dr.Reddys Laboratories informs about f
Dr.Reddys Laboratories has informed that the Company has filed its unaud..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit39945669
Gross Profit 5704 6970
Operating Profit 779715339
Net Sales 2731793593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Fredun Pharma (BSE)
 361.90 (9.70%)
M.Cap ( in Cr)144.38
Themis Medicare (BSE)
 305.00 (8.73%)
M.Cap ( in Cr)280.02
Everest Organics (BSE)
 157.65 (16.86%)
M.Cap ( in Cr)126.12
Pfizer (BSE)
 2907.45 (0.58%)
M.Cap ( in Cr)13300.92
Jenburkt Pharma (BSE)
 474.90 (3.28%)
M.Cap ( in Cr)217.95
Shareholding Pattern
PROMOTERS 26.77%
NON-INSTITUTION 13.94%
MUTUAL FUNDS/UTI 10.42%
FI/BANKS/INSURANCE 5.54%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM